← Leaderboards
Khaled Hassan
University Of Michigan At Ann Arbor
$874,320
Attributed
$874,320
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $175K · FY2011–15$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$874,320 · 1
By mechanism
K08$874,320 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Max S. Wicha$49,028,071
- Xing Fan$5,437,064
- Daniel Dimaio$34,640,869
- Linda C Samuelson$12,939,157
- Charles F Burant$27,360,950
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantApoptosisApoptoticBaseBiologic CharacteristicCancer CellCancer Cell LineCancer EtiologyCancer RecurrenceCancer Stem CellCancer TherapyCell Cycle ArrestCell DeathCell LineCell MaintenanceCell NucleusCell ProliferationCellsCessation Of LifeChemotherapyClinical TrialsCofactorColorectal CancerAdenocarcinoma
Grant awards (5)
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma$174,960
K08 · FY2015 · CA · contact PI
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma$174,960
K08 · FY2014 · CA · contact PI
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma$174,800
K08 · FY2013 · CA · contact PI
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma$174,800
K08 · FY2012 · CA · contact PI
Assessing the Notch Pathway as a Therapeutic Target in Lung Cancer Adenocarcinoma$174,800
K08 · FY2011 · CA · contact PI